冠状病毒病2019患者院内心脏骤停后生存率的多中心评估
这项回顾性队列研究纳入克利夫兰诊所医疗系统多家医院2020年3月1日至2020年10月15日期间住院的3555例冠状病毒病2019成人患者,其中58例发生需要心肺复苏的院内心脏骤停。心脏骤停多发生在重症监护环境(51/58,87.9%),初始心律以无脉性电活动为主(63.8%)。35例(60.3%)恢复自主循环,13例(22.4%)存活出院。作者结论认为该生存率与冠状病毒病2019大流行前相似。
要点
- 冠状病毒病2019患者院内心脏骤停后出院生存率为22.4%(13/58),恢复自主循环率为60.3%(35/58)。
- 心脏骤停主要发生在重症监护环境(51/58,87.9%),病房发生7/58(12.1%)。
- 心脏骤停前58.6%(34/58)患者接受机械通气,中位通气时长9天(四分位距2-18天);44%(24/58)使用血管升压药。
- 初始心律为无脉性电活动63.8%、无收缩29.3%、无脉性室性心动过速/心室颤动6.9%。
- 作者结论:冠状病毒病2019患者院内心脏骤停后生存率与疫情前相似。
适用人群与场景
- 年龄≥18岁、诊断为冠状病毒病2019、入住克利夫兰诊所医疗系统并发生需要心肺复苏的院内心脏骤停的成人患者。
研究设计与关键结果
- 研究类型:回顾性队列研究;场景:克利夫兰诊所医疗系统多家医院;时间:2020年3月1日至2020年10月15日。
- 3555例冠状病毒病2019患者住院,1372例入住ICU,58例发生院内心脏骤停。
- 队列中位年龄66.5岁(四分位距55.0-76.0岁),男性62.5%,白人53.4%,中位体重指数29.7(四分位距25.8-34.6)。
- 心脏骤停地点:ICU 51/58(87.9%),病房7/58(12.1%)。
- 心脏骤停前状态:机械通气34/58(58.6%),中位通气时长9天(四分位距2-18天);使用血管升压药24/58(44%)。
- 初始心律:无脉性电活动63.8%,无收缩29.3%,无脉性室性心动过速/心室颤动6.9%。
- 结局:恢复自主循环35/58(60.3%),存活出院13/58(22.4%)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:冠状病毒病2019患者院内心脏骤停后出院生存率为22%,与冠状病毒病2019大流行前相似。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: In-hospital cardiac arrest survival among coronavirus disease 2019 patients has been reported to range from 0% to 12%. These numbers are significantly lower than reported prepandemic in-hospital cardiac arrest survival rates of approximately 20-25% in the United States for non-coronavirus disease 2019 patients.
OBJECTIVE: To assess the incidence of in-hospital cardiac arrest survival of coronavirus disease 2019 patients.
DESIGN: A retrospective cohort study of adult patients with coronavirus disease 2019 subsequently found to have in-hospital cardiac arrest and underwent cardiopulmonary resuscitation (cardiopulmonary resuscitation).
SETTING: Multiple hospitals of the Cleveland Clinic Health System.
PATIENTS: All adult patients (age ≥ 18 yr) admitted to Cleveland Clinic Health System with a diagnosis of coronavirus disease 2019 who experienced in-hospital cardiac arrest requiring cardiopulmonary resuscitation.
MEASUREMENTS AND MAIN RESULTS: From March 01, 2020 to October 15, 2020, 3,555 patients with coronavirus disease 2019 were hospitalized; 1,372 were admitted to the ICU; 58 patients had in-hospital cardiac arrest. Median age of this cohort was 66.5 years (interquartile range, 55.0-76.0 yr). Patients were predominantly male (62.5%), White (53.4%), with a median body mass index of 29.7 (interquartile range, 25.8-34.6). Most in-hospital cardiac arrests were in critical care environments (ICU), 51 of 58 (87.9%); seven of 58 (12.1%) were on ward locations. Thirty-four of 58 patients (58.6%) were on mechanical ventilation prior to in-hospital cardiac arrest with a median duration of mechanical ventilation of 9 days (interquartile range, 2-18 d). Twenty-four of 58 patients (44%) were on vasopressors prior to arrest. Initial arrest rhythm was pulseless electrical activity at (63.8%), asystole (29.3%), and pulseless ventricular tachycardia/fibrillation (6.9%). Of the 58 patients, 35 (60.3%) attained return of spontaneous circulation, and 13 of 58 (22.4%) were discharged alive.
CONCLUSIONS: We report a 22% survival to discharge after in-hospital cardiac arrest in coronavirus disease 2019 patients, a survival rate similar to before the coronavirus disease 2019 pandemic.
参考来源
- Bhardwaj A, Alwakeel M, Saleem T, et al. A Multicenter Evaluation of Survival After In-Hospital Cardiac Arrest in Coronavirus Disease 2019 Patients. Crit Care Explor. 2021. PMID: 34036276. doi:10.1097/CCE.0000000000000425
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。